# Pharmacogenetic Treatments for Alcoholism

> **NCT01591291** · PHASE2,PHASE3 · WITHDRAWN · sponsor: **University of Virginia**

## Conditions studied

- Alcoholism

## Interventions

- **DRUG:** Ondansetron + Brief Behavioral Enhancement Treatment
- **DRUG:** Placebo + Brief Behavioral Enhancement Treatment

## Key facts

- **NCT ID:** NCT01591291
- **Lead sponsor:** University of Virginia
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2012-06
- **Primary completion:** 2017-12
- **Final completion:** 2018-02
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Grant was transferred to University of Maryland and results were reported under NCT02354703.
- **Last updated:** 2023-04-20

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01591291

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01591291, "Pharmacogenetic Treatments for Alcoholism". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01591291. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*